ACTide EDC (Electronic Data Capture) System against COVID-19
Nubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read moreNubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read moreNubilaria is providing it’s innovative ACTide EDC system free in support of a clinical study for COVID-19 related ARDS intensive
Read moreCanadian Altasciences completes its Phase I study on Gimsilumab to prevent and treat acute respiratory distress syndrome (ARDS) in COVID-19
Read moreThe European Commission has waived customs duty and VAT on medical devices imported from non-EU countries. A decision has been
Read moreThe widely used arthritis medicine Actemra (tocilizumab) has demonstrated “excellent effects” in the treatment of the COVID-19 disease. Roche’s promising
Read moreKaletra, a medicine containing two HIV drugs, lopinavir and ritonavir, which was considered as a potential treatment for the novel
Read moreRoche’s coronavirus test has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, the Swiss pharma giant
Read moreAscletis Pharma’s investigational Ganovo and Ritonavir combo-therapy shows promise in COVID-19 Clinical Trial. Chinese biotech Ascletis Pharma Inc. (HKEX code:
Read morePreclinical data on remdesivir indicates that the drug may have potential as a treatment against the new coronavirus COVID-19. Remdesivir
Read moreChina has approved Actemra to treat COVID-19 patients. Actemra, Roshe’s anti-inflammatory drug, has received the green light in China as
Read more